RxDoctor Payments Data

Mangaraju Chakka, MD

Clinical Cardiac Electrophysiology · Little Rock, ARNPI 1104862200

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,378 of the $7,058 with a category attached, or 76.2%. 24 manufacturers reported payments, led by Abbott at 25.2% of the total. Reporting peaked in 2019 at $2,691 and has fallen 62.1% since, to $1,020 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AR, where the typical reported total is $22,678.

$7,058in general payments, 2019–2025

Across 131 payments — averaging $53.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medical Device Business Services, Inc.$2K
  • Biosense Webster, Inc.$881
  • Boston Scientific$404
  • Atricure, Inc.$296
  • Johnson & Johnson$296
  • plus $2K from 18 others
$1,087,856in research payments, 2019–2025

Across 129 payments — averaging $8433.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1.1M
  • Abbott$9K
  • Boston Scientific$3K

What the payments were for

  • Travel & lodging$1,65924%
  • Food & beverage$5,37876%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,058 in reported general payments places this provider in the 15th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.

See all clinical cardiac electrophysiology providers in Arkansas

Medicare billing

Part B allowed, 2024
$355,501
Medicare patients
1,117
Services billed
4,716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban776$547,145
EntrestoSacubitril/Valsartan233$184,389
MultaqDronedarone Hcl173$181,002
XareltoRivaroxaban92$88,264
FarxigaDapagliflozin Propanediol76$45,871
JardianceEmpagliflozin62$38,531
Dofetilide163$25,151
Metoprolol Succinate1,114$17,632
CorlanorIvabradine Hcl16$15,644
Mexiletine Hcl96$6,287
Dabigatran EtexilateDabigatran Etexilate Mesylate11$4,736
Amiodarone Hcl309$4,166
Potassium Chloride271$4,054
SotalolSotalol Hcl206$2,880
Nebivolol Hcl47$2,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$192$184,389233 claims
Sanofi-aventis U.S. LLCMultaq$12$181,002173 claims
Johnson & JohnsonXarelto$296$88,26492 claims
AstraZenecaFarxiga$115$45,87176 claims
Boehringer IngelheimJardiance$13$38,53162 claims
AmgenCorlanor$135$15,64416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.

Other clinical cardiac electrophysiology in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →